Teva Pharmaceuticals stocks soar following Mylan takeover speculations

April 18, 2015 4:05 PM

62 0

Generic drugmaker Mylan NV moved quickly on Friday to pour cold water on published reports that Teva Pharmaceuticals Industries is considering a bid to acquire it.

Mylan last week announced a $29 billion offer to buy Perrigo Co Plc in a move that some analysts suggested was a tactic to help fend off an acquisition by larger rival Teva. Mylan Executive Chairman and former Chief Executive Officer Robert Coury said the Perrigo plans remain on track.

Read more

To category page